SANDRA CHARLES: Open Payments
NPI 1093734436 · SELINSGROVE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 31 payments from 14 companies in 2025. Trend: 2023 $998 · 2024 $978 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $140 |
| Novo Nordisk Inc | 5 | $85 |
| Lilly USA, LLC | 4 | $77 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| ACADIA Pharmaceuticals Inc | 2 | $42 |
| Indivior Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Exact Sciences Corporation | 1 | $25 |
| PFIZER INC. | 1 | $24 |
Products named: BREZTRI, DAYBUE, MOUNJARO, JARDIANCE, SUBLOCADE, Ozempic, AIRSUPRA, ROTATEQ.
Industry payments across PA — which companies pay providers there.
